TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
BB Healthcare Trust plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
ü |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
Type 1 disclosure as per the Transparency Directive II Regulation |
ü |
||
3. Full name of person(s) subject to the |
Schroders plc |
|||
4. Full name of shareholder(s) |
|
|||
5. Date of the transaction and date on |
12.01.17 |
|||
6. Date on which issuer notified: |
13.01.17 |
|||
7. Threshold(s) that is/are crossed or |
Above 5% |
|||
8. Notified details: |
||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||
Ordinary |
Below 5%
|
Below 5%
|
8,064,100
|
N/A
|
8,064,100
|
N/A
|
5.068%
|
|||||||
GB00BZCNLL95
|
||||||||||||||
|
||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||
|
|
|
|
|
||||||||||
|
||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||
|
|
|||||||||||||
|
||||||||||||||
Total (A+B+C) |
||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||
8,064,100 |
5.068% |
|||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
Schroder & Co. Limited 7,746,100 4.868%
Schroders (C.I.) Limited 318,000 0.002% |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 159,131,100. |
|
14. Contact name: |
Chloe Talbot |
|
15. Contact telephone number: |
020 7658 6000 |
|
Enquiries:
Anthony Lee |
020 7653 9690 |
PraxisIFM Fund Services (UK) Limited |
|